Study protocol for BeWEL: the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas

Angela Craigie, Stephen Caswell, Caron Paterson, Shaun Treweek, Jill Belch, Fergus Daly, Jackie Rodger, Joyce Thompson, Alison Kirk, Anne Ludbrook, Martine Stead, Jane Wardle, Robert Steele, Annie Anderson

Research output: Contribution to journalArticle

22 Citations (Scopus)
6 Downloads (Pure)

Abstract

Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second highest cause of cancer death in the UK. Most cases occur in people over 50 years and CRC often co-exists with other lifestyle related disorders including obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). These diseases share risk factors related to the metabolic syndrome including large body size, abnormal lipids and markers of insulin resistance indicating common aetiological pathways.
Methods/Design: This 3 year study will be a two-arm, multicentre, randomised controlled trial comparing the BeWEL lifestyle (diet, physical activity and behaviour change) programme against usual care. The pre-trial development will take 6 months and participants will be recruited over a 12 month period and undertake the intervention and follow up for 12 months (total 24 months recruitment and intervention implementation) with a further 6 months for data collection, analysis and interpretation. Four hundred and fifty two participants who have had a colorectal adenoma detected and removed (through the
national colorectal screening programme) will provide 80% power to detect a weight loss of 7% over 12 months. Primary outcomes are changes in body weight and waist circumference. Secondary outcomes will include cardiovascular risk factors, psycho-social measures and intervention costs.
Discussion: The results from this study will enhance the evidence base for lifestyle change in patients at higher risk of chronic disease including obesity related cancers. International Standard Randomised Controlled Trials No: ISRCTN53033856
Original languageEnglish
Article number184
Number of pages8
JournalBMC Public Health
Volume11
DOIs
Publication statusPublished - 25 Mar 2011

Fingerprint

Adenoma
Life Style
Exercise
Colorectal Neoplasms
Randomized Controlled Trials
Obesity
Body Weight Changes
Second Primary Neoplasms
Body Size
Waist Circumference
Type 2 Diabetes Mellitus
Insulin Resistance
Weight Loss
Cause of Death
Neoplasms
Chronic Disease
Cardiovascular Diseases
Diet
Lipids
Costs and Cost Analysis

Cite this

Study protocol for BeWEL : the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas. / Craigie, Angela ; Caswell, Stephen; Paterson, Caron; Treweek, Shaun; Belch, Jill; Daly, Fergus; Rodger, Jackie; Thompson, Joyce; Kirk, Alison ; Ludbrook, Anne; Stead, Martine; Wardle, Jane; Steele, Robert; Anderson, Annie.

In: BMC Public Health, Vol. 11, 184, 25.03.2011.

Research output: Contribution to journalArticle

Craigie, A, Caswell, S, Paterson, C, Treweek, S, Belch, J, Daly, F, Rodger, J, Thompson, J, Kirk, A, Ludbrook, A, Stead, M, Wardle, J, Steele, R & Anderson, A 2011, 'Study protocol for BeWEL: the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas' BMC Public Health, vol. 11, 184. https://doi.org/10.1186/1471-2458-11-184
Craigie, Angela ; Caswell, Stephen ; Paterson, Caron ; Treweek, Shaun ; Belch, Jill ; Daly, Fergus ; Rodger, Jackie ; Thompson, Joyce ; Kirk, Alison ; Ludbrook, Anne ; Stead, Martine ; Wardle, Jane ; Steele, Robert ; Anderson, Annie. / Study protocol for BeWEL : the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas. In: BMC Public Health. 2011 ; Vol. 11.
@article{b146d4526d5849c388f97687178e7cf4,
title = "Study protocol for BeWEL: the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas",
abstract = "Abstract Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second highest cause of cancer death in the UK. Most cases occur in people over 50 years and CRC often co-exists with other lifestyle related disorders including obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). These diseases share risk factors related to the metabolic syndrome including large body size, abnormal lipids and markers of insulin resistance indicating common aetiological pathways. Methods/Design: This 3 year study will be a two-arm, multicentre, randomised controlled trial comparing the BeWEL lifestyle (diet, physical activity and behaviour change) programme against usual care. The pre-trial development will take 6 months and participants will be recruited over a 12 month period and undertake the intervention and follow up for 12 months (total 24 months recruitment and intervention implementation) with a further 6 months for data collection, analysis and interpretation. Four hundred and fifty two participants who have had a colorectal adenoma detected and removed (through the national colorectal screening programme) will provide 80{\%} power to detect a weight loss of 7{\%} over 12 months. Primary outcomes are changes in body weight and waist circumference. Secondary outcomes will include cardiovascular risk factors, psycho-social measures and intervention costs. Discussion: The results from this study will enhance the evidence base for lifestyle change in patients at higher risk of chronic disease including obesity related cancers. International Standard Randomised Controlled Trials No: ISRCTN53033856",
author = "Angela Craigie and Stephen Caswell and Caron Paterson and Shaun Treweek and Jill Belch and Fergus Daly and Jackie Rodger and Joyce Thompson and Alison Kirk and Anne Ludbrook and Martine Stead and Jane Wardle and Robert Steele and Annie Anderson",
year = "2011",
month = "3",
day = "25",
doi = "10.1186/1471-2458-11-184",
language = "English",
volume = "11",
journal = "BMC Public Health",
issn = "1471-2458",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Study protocol for BeWEL

T2 - the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas

AU - Craigie, Angela

AU - Caswell, Stephen

AU - Paterson, Caron

AU - Treweek, Shaun

AU - Belch, Jill

AU - Daly, Fergus

AU - Rodger, Jackie

AU - Thompson, Joyce

AU - Kirk, Alison

AU - Ludbrook, Anne

AU - Stead, Martine

AU - Wardle, Jane

AU - Steele, Robert

AU - Anderson, Annie

PY - 2011/3/25

Y1 - 2011/3/25

N2 - Abstract Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second highest cause of cancer death in the UK. Most cases occur in people over 50 years and CRC often co-exists with other lifestyle related disorders including obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). These diseases share risk factors related to the metabolic syndrome including large body size, abnormal lipids and markers of insulin resistance indicating common aetiological pathways. Methods/Design: This 3 year study will be a two-arm, multicentre, randomised controlled trial comparing the BeWEL lifestyle (diet, physical activity and behaviour change) programme against usual care. The pre-trial development will take 6 months and participants will be recruited over a 12 month period and undertake the intervention and follow up for 12 months (total 24 months recruitment and intervention implementation) with a further 6 months for data collection, analysis and interpretation. Four hundred and fifty two participants who have had a colorectal adenoma detected and removed (through the national colorectal screening programme) will provide 80% power to detect a weight loss of 7% over 12 months. Primary outcomes are changes in body weight and waist circumference. Secondary outcomes will include cardiovascular risk factors, psycho-social measures and intervention costs. Discussion: The results from this study will enhance the evidence base for lifestyle change in patients at higher risk of chronic disease including obesity related cancers. International Standard Randomised Controlled Trials No: ISRCTN53033856

AB - Abstract Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second highest cause of cancer death in the UK. Most cases occur in people over 50 years and CRC often co-exists with other lifestyle related disorders including obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). These diseases share risk factors related to the metabolic syndrome including large body size, abnormal lipids and markers of insulin resistance indicating common aetiological pathways. Methods/Design: This 3 year study will be a two-arm, multicentre, randomised controlled trial comparing the BeWEL lifestyle (diet, physical activity and behaviour change) programme against usual care. The pre-trial development will take 6 months and participants will be recruited over a 12 month period and undertake the intervention and follow up for 12 months (total 24 months recruitment and intervention implementation) with a further 6 months for data collection, analysis and interpretation. Four hundred and fifty two participants who have had a colorectal adenoma detected and removed (through the national colorectal screening programme) will provide 80% power to detect a weight loss of 7% over 12 months. Primary outcomes are changes in body weight and waist circumference. Secondary outcomes will include cardiovascular risk factors, psycho-social measures and intervention costs. Discussion: The results from this study will enhance the evidence base for lifestyle change in patients at higher risk of chronic disease including obesity related cancers. International Standard Randomised Controlled Trials No: ISRCTN53033856

U2 - 10.1186/1471-2458-11-184

DO - 10.1186/1471-2458-11-184

M3 - Article

VL - 11

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

M1 - 184

ER -